Cost–benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched Analysis

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben de Pauw, Thomas J. Walsh, J. Peter Donnelly et al. · Clinical Infectious Diseases · 2008 · 4.9K citations · Full text

Veterinary Medicine, Infectious Diseases, Oncology +7

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz et al. · Clinical Infectious Diseases · 2011 · 3.4K citations

Pharmacy, Infectious Diseases, Oncology +17

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Oliver A. Cornely, Johan Maertens, Drew J. Winston et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

Andrew J. Ullmann, Jeffrey H. Lipton, David H. Vesole et al. · New England Journal of Medicine · 2007 · 1.3K citations · Full text

Medicine, Infectious Diseases, Stem Cell Transplantation +11

Reducing bias in a propensity score matched-pair sample using greedy matching techniques

L Parsons · Medical Entomology and Zoology · 2001 · 736 citations

Public Health, Biostatistics, Causal Inference +10